Wednesday, 7 October 2026 Sign in

Owkin alum raises $25m seed to build world model for human cells

Sifted 7 October 2026, 14:00

Rivercell, a Paris-based biotech, raised a $25m seed round to build an AI model aimed at understanding and predicting human cell behavior for drug discovery. The funding amount is $25m. The company will use the money to develop and refine its human-cell “world model” to support faster drug discovery.

Every AI story that matters,
in your inbox by 8am.

TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.

TLDRocket 7 October 2026

The biggest throughline today was a blunt reality check on personal AI: getting useful answers is only half the work; earning trust is the other half. Tony Fadell told MIT Future Fest that the first wave of AI gadgets—Rabbit R1, Humane’s AI pin, and Limitless’ pendant—didn’t die because the models were bad. They failed to solve real needs, and consumers didn’t trust what those devices were doing. His point landed right as OpenAI’s Alexander Embiricos is set to talk at TechCrunch Disrupt 2026 about what comes after the chatbot with Dots, positioning next-step personal agents around privacy and security. The subtext is that “assistant” has to mean something measurable, not just conversational.

Read the full briefing →

Owkin alum raises $25m seed to build world model for human cells

Related stories

Every AI story that matters, in your inbox by 8am.

Every AI story that matters,
in your inbox by 8am.